Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biovaxys Technology Corp (BVAXF)

Biovaxys Technology Corp (BVAXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0329 +50.15%
on 10/22/24
0.0600 -17.67%
on 11/05/24
+0.0115 (+30.34%)
since 10/18/24
3-Month
0.0290 +70.34%
on 10/16/24
0.0600 -17.67%
on 11/05/24
+0.0158 (+47.02%)
since 08/16/24
52-Week
0.0091 +442.86%
on 12/08/23
0.0758 -34.83%
on 02/26/24
+0.0235 (+90.73%)
since 11/17/23

Most Recent Stories

More News
BioVaxys to Participate in the US Government Biomedical Advanced Research and Development Authority (BARDA) Rapid Response Partnership Vehicle (RRPV) Vaccine Development Consortium

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") is pleased to announce that it has been invited to and...

BVAXF : 0.0494 (unch)
BIOV.CN : 0.0650 (-7.14%)
BioVaxys' DPX Exhibits Superior Immune System Activation Compared to Aqueous and Emulsion-Based Antigen Delivery Systems

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights studies showing that its novel immune...

BVAXF : 0.0494 (unch)
BIOV.CN : 0.0650 (-7.14%)
BioVaxys to Present at the Emerging Growth Conference on October 30th, 2024

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") a clinical-stage company developing a portfolio of...

BVAXF : 0.0494 (unch)
BIOV.CN : 0.0650 (-7.14%)
BioVaxys Engages Dr. Rajkannan Rajagopalan as Vaccine Formulations Advisor

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the "Company") is pleased to announce that it has engaged Rajkannan Rajagopalan, PhD,...

BVAXF : 0.0494 (unch)
BIOV.CN : 0.0650 (-7.14%)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
BNTX : 101.65 (+1.94%)
CVAC : 2.52 (-0.79%)
VXRT : 0.6156 (+6.12%)
IBRX : 4.74 (+5.57%)
BioVaxys to Present New Data on its DPX Immune Educating Platform at Personalized Cancer Vaccine Summit

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the Company") is pleased to announce that it has been invited to...

BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

LEXX : 2.06 (+2.49%)
BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
TFFP : 0.3432 (-8.75%)
DNTH : 23.25 (-0.47%)
AQST : 4.58 (+3.15%)
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases

/CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential of its novel lipid-in-oil...

BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
Sustainable Agriculture: The Growing Need for Biotech Innovations in the World's Food Supplies

/CNW/ -- USA News Group – How we take care of the planet, and the food we eat is rapidly shifting. Back in May, the World Economic Forum addressed how...

BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
ZTS : 176.35 (+0.69%)
CTVA : 56.34 (+2.05%)
BG : 91.27 (+1.50%)
BRFS : 4.10 (-4.87%)
Innovative Agritech Solutions Powering the Future of Sustainable Agriculture

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – How we take care of the planet,...

BIOV.CN : 0.0650 (-7.14%)
BVAXF : 0.0494 (unch)
ZTS : 176.35 (+0.69%)
CTVA : 56.34 (+2.05%)
BG : 91.27 (+1.50%)
BRFS : 4.10 (-4.87%)

Key Turning Points

3rd Resistance Point 0.0543
2nd Resistance Point 0.0520
1st Resistance Point 0.0507
Last Price 0.0494
1st Support Level 0.0471
2nd Support Level 0.0448
3rd Support Level 0.0435

See More

52-Week High 0.0758
Fibonacci 61.8% 0.0503
Last Price 0.0494
Fibonacci 50% 0.0424
Fibonacci 38.2% 0.0346
52-Week Low 0.0091

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar